Harry G. McCoy, Pharm.D. – Chairman, North Shore InnoVentures and President & CEO of Thorne Diagnostics (www.thornediagnostics.com), a molecular diagnostics company in Beverly, MA. Dr. McCoy is a former academic who has founded and run private and public Life Sciences companies for more than 20 years. Former President, Hamilton Thorne Biosciences (stem cell tools), Executive Chairman & President of MEDTOX Scientific (Nasdaq:MTOX), Editek (AMEX:EDI), among others. Currently Chairman of Attogen (an early-stage drug discovery company), Director of Hamilton Thorne Biosciences and the University of Minnesota College of Pharmacy Board of Advisors, and a Director of the North Shore Technology Council. Dr. McCoy has achieved 24 – 40 fold returns for his investors and was also Director of Apptec, a venture-backed biopharmaceutical manufacturing firm which was purchased by WuXi PharmaTech (Nasdaq:WX) last year, which was the largest acquisition of a U.S. company by a Chinese company since Lenova purchased the IBM computer unit, forming the world’s fourth largest pharmaceutical company in the world. B.A. (Biology) UC San Diego, Pharm.D. UC San Francisco, post-doctoral fellowship University of Minnesota.